Your browser doesn't support javascript.
loading
Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)-insights of people affected by cancer and healthcare professionals: a qualitative study protocol.
Jennings, Stephen; Anstey, Sally; Bower, Janet; Brewster, Alison; Buckman, John; Fenlon, Deborah; Fitzsimmons, Deborah; Watts, Tessa.
Afiliação
  • Jennings S; School of Healthcare Sciences, Cardiff University, Cardiff, UK.
  • Anstey S; School of Healthcare Sciences, Cardiff University, Cardiff, UK.
  • Bower J; Chemotherapy Day Unit, Hywel Dda University Health Board, Haverfordwest, UK.
  • Brewster A; South West Wales Cancer Centre, Swansea Bay University Health Board, Swansea, UK.
  • Buckman J; PPI representative, Swansea, UK.
  • Fenlon D; Department of Nursing, College of Human and Health Sciences, Swansea University, Swansea, UK.
  • Fitzsimmons D; Swansea Centre for Health Economics, College of Human and Health Sciences, Swansea University, Swansea, UK.
  • Watts T; School of Healthcare Sciences, Cardiff University, Cardiff, UK wattst1@cardiff.ac.uk.
BMJ Open ; 11(5): e043750, 2021 05 27.
Article em En | MEDLINE | ID: mdl-34045214

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article